NS Pharma Announces Change in Commercial Leadership

The company is developing innovative therapies for rare diseases like the exon-skipping therapy VILTEPSO®. PARAMUS, N.J., Nov. 26, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma) announced a change of leadership within its Commercial division. Effective September 9, 2024, Donald Foy –...